{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:41:13Z","timestamp":1787614873503,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1124\/jpet.114.221176","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T01:42:37Z","timestamp":1426124557000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease"],"prefix":"10.1016","volume":"353","author":[{"given":"Sudipta","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Shlyakhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco G.","family":"Salituro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Hoock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.114.221176_bib1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/emboj\/18.6.1549","article-title":"Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain","volume":"18","author":"Cacalano","year":"1999","journal-title":"EMBO J"},{"key":"10.1124\/jpet.114.221176_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.berh.2010.10.001","article-title":"Rheumatoid arthritis","volume":"24","author":"Carmona","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1124\/jpet.114.221176_bib3","doi-asserted-by":"crossref","unstructured":"Catlett, IM, Luo X, Penney MS, Pray ME, Spencer-Green G, Botfield M, and Hoock T (2012) Biomarker Assessment of VX-509, an Investigational Selective Inhibitor, in Healthy Volunteers. European League Against Rheumatism (EULAR) Congress; 2012 Jun 6\u20139; Berlin, Germany. EULAR Poster 2012 (THU0141).","DOI":"10.1136\/annrheumdis-2012-eular.2106"},{"key":"10.1124\/jpet.114.221176_bib4","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1021\/bi9919495","article-title":"Kinetic mechanism of the p38-alpha MAP kinase: phosphoryl transfer to synthetic peptides","volume":"39","author":"Chen","year":"2000","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.114.221176_bib5","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1124\/jpet.114.221176_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1124\/jpet.114.221176_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/jpet.114.221176_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1124\/jpet.114.221176_bib9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood.V94.3.932.415k30_932_939","article-title":"Dysregulated myelopoiesis in mice lacking Jak3","volume":"94","author":"Grossman","year":"1999","journal-title":"Blood"},{"key":"10.1124\/jpet.114.221176_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-9525(00)89000-9","article-title":"Jaks and Stats in signaling by the cytokine receptor superfamily","volume":"11","author":"Ihle","year":"1995","journal-title":"Trends Genet"},{"key":"10.1124\/jpet.114.221176_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jlb.60.4.441","article-title":"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency","volume":"60","author":"Johnston","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1124\/jpet.114.221176_bib12","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.4049\/jimmunol.159.9.4350","article-title":"Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement","volume":"159","author":"Karras","year":"1997","journal-title":"J Immunol"},{"key":"10.1124\/jpet.114.221176_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors"},{"key":"10.1124\/jpet.114.221176_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/377065a0","article-title":"Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)","volume":"377","author":"Macchi","year":"1995","journal-title":"Nature"},{"key":"10.1124\/jpet.114.221176_bib15","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.114.221176_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/B978-0-444-62652-3.00004-1","article-title":"Advances in the discovery of selective JAK inhibitors","volume":"52","author":"Menet","year":"2013","journal-title":"Prog Med Chem"},{"key":"10.1124\/jpet.114.221176_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","article-title":"Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells","volume":"10","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"10.1124\/jpet.114.221176_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/366129a0","article-title":"The protein tyrosine kinase JAK1 complements defects in interferon-alpha\/beta and -gamma signal transduction","volume":"366","author":"M\u00fcller","year":"1993","journal-title":"Nature"},{"key":"10.1124\/jpet.114.221176_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1124\/jpet.114.221176_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.270.5237.800","article-title":"Defective lymphoid development in mice lacking Jak3","volume":"270","author":"Nosaka","year":"1995","journal-title":"Science"},{"key":"10.1124\/jpet.114.221176_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O\u2019Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1124\/jpet.114.221176_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1124\/jpet.114.221176_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/1074-7613(95)90066-7","article-title":"Developmental defects of lymphoid cells in Jak3 kinase-deficient mice","volume":"3","author":"Park","year":"1995","journal-title":"Immunity"},{"key":"10.1124\/jpet.114.221176_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(00)81166-6","article-title":"Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses","volume":"93","author":"Rodig","year":"1998","journal-title":"Cell"},{"key":"10.1124\/jpet.114.221176_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.270.5237.797","article-title":"Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development","volume":"270","author":"Russell","year":"1995","journal-title":"Science"},{"key":"10.1124\/jpet.114.221176_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1124\/jpet.114.221176_bib27","series-title":"In Vivo Models of Inflammation: Progress in Inflammation Research","author":"Stevenson","year":"2006"},{"key":"10.1124\/jpet.114.221176_bib28","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1182\/blood.V87.8.3103.bloodjournal8783103","article-title":"Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene","volume":"87","author":"Taylor","year":"1996","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1124\/jpet.114.221176_bib29","first-page":"76","article-title":"Roles of JAK kinase in human GM-CSF receptor signals","volume":"11","author":"Watanabe","year":"1997","journal-title":"Leukemia"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.114.221176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:59:21Z","timestamp":1739987961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524190155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0022356524190155"],"URL":"https:\/\/doi.org\/10.1124\/jpet.114.221176","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.114.221176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}